12/18
08:07 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $68.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $68.00 price target on the stock.
12/16
11:20 am
halo
How Much Upside is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08% [Yahoo! Finance]
Low
Report
How Much Upside is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08% [Yahoo! Finance]
12/11
11:22 am
halo
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy? [Yahoo! Finance]
Low
Report
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy? [Yahoo! Finance]
12/9
11:58 am
halo
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock [Yahoo! Finance]
Low
Report
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock [Yahoo! Finance]
12/9
10:49 am
halo
Is Halozyme Therapeutics (HALO) Stock Undervalued Right Now? [Yahoo! Finance]
Low
Report
Is Halozyme Therapeutics (HALO) Stock Undervalued Right Now? [Yahoo! Finance]
12/5
01:45 pm
halo
HALO vs. FOLD: Which Stock Is the Better Value Option? [Yahoo! Finance]
Low
Report
HALO vs. FOLD: Which Stock Is the Better Value Option? [Yahoo! Finance]
12/5
11:49 am
halo
Is Halozyme Therapeutics (HALO) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Halozyme Therapeutics (HALO) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
12/3
09:42 am
halo
Exploring Three High Growth Tech Stocks in the United States [Yahoo! Finance]
Low
Report
Exploring Three High Growth Tech Stocks in the United States [Yahoo! Finance]
11/27
08:30 am
halo
Halozyme to Present at Upcoming Investor Conferences
Low
Report
Halozyme to Present at Upcoming Investor Conferences
11/25
12:37 pm
halo
HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up [Yahoo! Finance]
Low
Report
HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up [Yahoo! Finance]
11/22
11:44 am
halo
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
11/22
08:35 am
halo
Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
Medium
Report
Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
11/21
11:28 am
halo
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock [Yahoo! Finance]
Low
Report
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock [Yahoo! Finance]
11/20
10:24 am
halo
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $68.00 price target on the stock.
Low
Report
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $68.00 price target on the stock.
11/19
12:55 pm
halo
HALO vs. FOLD: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]
Low
Report
HALO vs. FOLD: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]
11/19
10:51 am
halo
Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now? [Yahoo! Finance]
Low
Report
Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now? [Yahoo! Finance]
11/19
10:51 am
halo
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? [Yahoo! Finance]
11/18
07:12 am
halo
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec [Yahoo! Finance]
Medium
Report
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec [Yahoo! Finance]
11/18
07:00 am
halo
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
Medium
Report
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
11/17
08:01 pm
halo
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says [Yahoo! Finance]
Medium
Report
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says [Yahoo! Finance]
11/15
11:54 am
halo
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock [Yahoo! Finance]
11/14
05:35 pm
halo
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance Canada]
High
Report
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance Canada]
11/14
04:27 pm
halo
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction [Yahoo! Finance]
High
Report
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction [Yahoo! Finance]
11/14
04:15 pm
halo
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
High
Report
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
11/14
03:55 pm
halo
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance]
Low
Report
Germany's Evotec Gets Takeover Interest From Halozyme [Yahoo! Finance]